ALV Form 4: Laurie Brlas Receives 11.5121 RSUs, Vesting by 2026

Rhea-AI Filing Summary

Laurie Brlas, a director of Autoliv Inc. (ALV), was granted restricted stock units (RSUs) on 09/23/2025. The award shows 11.5121 RSUs granted (each RSU converts to one share) with no cash purchase price. After the grant, Ms. Brlas beneficially owned 1,728.5767 shares of Autoliv common stock on a direct basis. The grant includes dividend-equivalent rights that accrue as additional RSUs and follows the award agreement's dividend treatment. The RSUs vest and convert to shares in one installment on the earlier of Autoliv’s 2026 annual meeting or the one-year anniversary of May 8, 2025. The Form 4 was signed by Brian Kelly by power of attorney on 09/24/2025.

Positive

• Director alignment: Grant increases the reporting person’s direct equity stake, aligning interests with shareholders.
• Dividend-equivalent treatment: Cash dividends accrue as additional RSUs, preserving economic participation in dividends.
• Clear vesting conditions: Vesting schedule is explicitly disclosed, tied to 2026 annual meeting or contractual one-year anniversary.

Negative

• Contingent vesting: RSUs do not convert to shares immediately; they remain contingent until the stated vesting event.
• Modest size: The grant of 11.5121 RSUs is small and unlikely to be materially impactful to ownership or incentives.

Insights

Financial Analyst

TL;DR: Director received a small, typical RSU grant that modestly increases direct share ownership and aligns compensation with shareholder value.

The 11.5121 RSU award is modest relative to total outstanding shares and results in 1,728.5767 shares beneficially owned by the reporting person after the transaction. The inclusion of dividend-equivalent rights means the grant will capture cash dividend value as additional RSUs subject to the same vesting schedule, preserving the economic alignment between executive compensation and shareholder returns. No cash price was paid for these units, and vesting is time/meeting contingent, delaying full shareholder dilution and transfer of voting rights until conversion.

Corporate Governance Expert

TL;DR: Grant terms are standard governance practice: time-based vesting with dividend equivalents; disclosure is complete and timely.

The filing clearly discloses the grant date, amount, dividend-equivalent treatment, and vesting triggers tied to the 2026 annual meeting or a contractual one-year anniversary. Use of a power of attorney signature is noted and acceptable for Form 4 filings. From a governance perspective, this is a routine director equity award intended to align interests without immediate transfer of control or significant dilution.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BRLAS LAURIE

(Last) (First) (Middle)

C/O AUTOLIV, INC.

KLARABERGSVIADUKTEN 70, SECTION D5

(Street)

STOCKHOLM V7 SE-111 64

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AUTOLIV INC [ ALV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	09/23/2025		A(2)		11.5121		(3)	(3)	Common Stock	11.5121	$0	1,728.5767	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock.

2. Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs.

3. The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025.

	Brian Kelly by POA from Laurie Brlas	09/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Laurie Brlas (ALV) receive on 09/23/2025?

The Form 4 shows a grant of 11.5121 restricted stock units (RSUs) on 09/23/2025.

How many Autoliv shares does Laurie Brlas beneficially own after the transaction?

The filing reports 1,728.5767 shares beneficially owned following the reported transaction.

When do the RSUs vest and convert to shares?

The RSUs vest and convert in one installment on the earlier of Autoliv’s 2026 annual stockholder meeting or the one-year anniversary of May 8, 2025.

Were dividends included in the RSU award?

Yes. Dividend equivalents accrue as additional RSUs and follow the same vesting schedule as the underlying RSUs.

Was any cash paid for these RSUs and who signed the form?

The RSUs show a $0 price and the Form 4 was signed by Brian Kelly by power of attorney on 09/24/2025.